Renata PLC (DSE: RENATA)

Market Cap	60.34B
Revenue (ttm)	39.91B
Net Income (ttm)	2.96B
Shares Out	114.70M
EPS (ttm)	25.79
PE Ratio	20.40
Forward PE	n/a
Dividend	9.20 (1.75%)
Ex-Dividend Date	Oct 22, 2024

Volume	30,310
Average Volume	16,648
Open	535.00
Previous Close	534.20
Day's Range	525.00 - 536.00
52-Week Range	525.00 - 1,217.90
Beta	0.08
RSI	12.22
Earnings Date	Jan 28, 2025

About Renata

Renata PLC manufactures, markets, and distributes human pharmaceuticals, animal health medicines, nutritionals, and vaccines in Bangladesh. Its pharmaceutical products include antimicrobials, anti-hypertensive, anti-angina, anti-diabetic, eye-ear and topical preparation, antigout, NSAID, anti-spasmodic, steroid, anti-osteoporotic, anti-allergic, cardiovascular, CNS, hormone, anti-cancer, oxytocic, anti-fibrinolytic, anti-asthma, expectorant, oral rehydration saline, narcotic analgesic, antipyretic/analgesic, antiemetic, anesthetic, antiviral, a...

• Industry: Pharmaceutical Preparations
• Founded: 1972
• Employees: 7,859
• Stock Exchange: Dhaka Stock Exchange
• Ticker Symbol: RENATA

Financial Performance

In 2024, Renata's revenue was 37.71 billion, an increase of 14.37% compared to the previous year's 32.97 billion. Earnings were 3.62 billion, an increase of 54.57%.